NEWARK, Calif., Sep 27, 2012 (GlobeNewswire via COMTEX) — StemCells,today announced that the first patient with an incomplete spinal cord injury has been enrolled in the Company’s Phase I/II clinical trial in chronic spinal cord injury and transplanted with the Company’s proprietary HuCNS-SC(R) neural stem…